Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Patient Preference and Adherence|September 23, 2021
Assessing Predictors of Tamoxifen Nonadherence in Patients with Early Breast CancerEmilia Montagna, Paola Zagami, Marianna Masiero, et al.
Breast Cancer Research and Treatment|January 8, 2025
Oral selective estrogen receptor degraders for breast cancer treatment: focus on pharmacological differencesRoberta Scafetta, Paola Zagami, Marzia Del Re, et al.
Cancer Treatment Reviews|September 9, 2021
Fed or fasted state for oral therapies in breast cancer treatment? A comprehensive review of clinical practice recommendationsEleonora Nicolò, Dario Trapani, Pier Paolo Maria Berton Giachetti, et al.
Ecancermedicalscience|November 19, 2020
The rare entity of bilateral and unilateral neuroendocrine metastases to the breast: a case series and literature reviewPaola Zagami, Eleni Kandaraki, Giuseppe Renne, et al.
European Journal of Cancer (Oxford, England : 1990)|September 2, 2021
Clinical outcomes of patients with metastatic breast cancer enrolled in phase I clinical trialsCarmen Criscitiello, Antonio Marra, Stefania Morganti, et al.
The Oncologist|August 14, 2020
Pretreatment Blood Parameters Predict Efficacy from Immunotherapy Agents in Early Phase Clinical TrialsCarmen Criscitiello, Antonio Marra, Stefania Morganti, et al.
Expert Opinion on Drug Metabolism & Toxicology|December 4, 2019
Pharmacodynamics, clinical findings and approval status of current and emerging tyrosine-kinase inhibitors for pancreatic neuroendocrine tumorsNicola Fazio, Chiara A Cella, Marzia Del Re, et al.
JCO Oncology Practice|November 20, 2023
Cardiotoxicity of Agents Used in Patients With Breast CancerPaola Zagami, Dario Trapani, Eleonora Nicolò, et al.
Expert Opinion on Pharmacotherapy|January 23, 2025
An update on promising and emerging protein kinase B/AKT inhibitors for breast cancerRiccardo Asnaghi, Gabriele Antonarelli, Elena Battaiotto, et al.
Pageof 6